Vivos Therapeutics (VVOS) Non-Current Assets (2019 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Non-Current Assets of $20.2 million for Q1 2026, up 163.5% year-over-year from $7.7 million in Q1 2025, and down 2.62% quarter-over-quarter from $20.8 million in Q4 2025.
Vivos Therapeutics (VVOS) Non-Current Assets (2019 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Non-Current Assets for 8 consecutive years, with $20.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets rose 163.5% year-over-year to $20.2 million; the TTM figure through Mar 2026 stood at $80.2 million (up 155.07% YoY), while the FY2025 annual figure was $20.8 million, up 165.88% from the prior year.
- Non-Current Assets retreated to $20.2 million in Q1 2026 per VVOS's latest filing, from $20.8 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $20.8 million in Q4 2025 and bottomed at $7.7 million in Q1 2025.
- Historically, Non-Current Assets has averaged $11.0 million across 5 years, with a median of $8.3 million in 2023.
- On a YoY basis, Non-Current Assets climbed as much as 165.88% in 2025 and fell as far as 6.32% in 2025.
- Vivos Therapeutics' Non-Current Assets stood at $8.3 million in 2022, then fell by 0.33% to $8.3 million in 2023, then declined by 5.54% to $7.8 million in 2024, then jumped by 165.88% to $20.8 million in 2025, then retreated by 2.62% to $20.2 million in 2026.
- Business Quant data shows VVOS's Non-Current Assets at $20.2 million in Q1 2026, $20.8 million in Q4 2025, and $19.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn | 19.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.22 Mn |
| Dec 31, 2025 | 20.77 Mn |
| Sep 30, 2025 | 19.86 Mn |
| Jun 30, 2025 | 19.30 Mn |
| Mar 31, 2025 | 7.68 Mn |
| Dec 31, 2024 | 7.81 Mn |
| Sep 30, 2024 | 7.95 Mn |
| Jun 30, 2024 | 7.99 Mn |
| Mar 31, 2024 | 8.19 Mn |
| Dec 31, 2023 | 8.27 Mn |
| Sep 30, 2023 | 8.33 Mn |
| Jun 30, 2023 | 8.41 Mn |
| Mar 31, 2023 | 8.39 Mn |
| Dec 31, 2022 | 8.30 Mn |
| Sep 30, 2022 | 8.70 Mn |
| Jun 30, 2022 | 8.86 Mn |
| Mar 31, 2022 | 7.96 Mn |
| Dec 31, 2021 | 6.37 Mn |
| Sep 30, 2021 | 6.99 Mn |
| Jun 30, 2021 | 6.77 Mn |